Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ELI LILLY & CoLLY · Entity 2794 | EVP, Global Quality | June 03, 2024 | June 03, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ELI LILLY & Co
Report date June 03, 2024 · Filed June 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,428 |
Reported balance
After 2024-06-03 transaction · row 1
1 source rowRow 1 · 2024-06-03 · Sale · Disposed 7,056 · Balance 25,428 F1: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $818.80 to $819.59, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 402 |
Reported balance
Holding disclosure · report date 2024-06-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 402 |
| Common StockSEC Table I · non-derivative | Indirect401(k) - by partner | 1,770 |
Reported balance
Holding disclosure · report date 2024-06-03 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,770 F3: The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | Indirectby partner | 128 |
Reported balance
Holding disclosure · report date 2024-06-03 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 128 F3: The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $818.80 to $819.59, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2024 Filed Jun 3, 2024 20:14 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 7,056 | $819.38 | $5,781,545.28 |
DisclosureSEC source: 0000059478-24-000139 · wk-form4_1717445655.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · EVP, Global Quality 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,428 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $818.80 to $819.59, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:19 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 1,308 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000036 · wk-form4_1707945531.xml · derivative · entry 5 Norton Johna · CIK 0001702471 · EVP, Global Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,308 Underlying: Common Stock · 1,308 shares Expires 2025-02-01 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:19 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 1,668 | $737.26 | $1,229,749.68 |
DisclosureSEC source: 0000059478-24-000036 · wk-form4_1707945531.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · EVP, Global Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,484 Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:24 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 1,268 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000017 · wk-form4_1706909035.xml · derivative · entry 6 Norton Johna · CIK 0001702471 · EVP, Global Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,268 shares Expires 2024-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:24 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 566 | $645.61 | $365,415.26 |
DisclosureSEC source: 0000059478-24-000017 · wk-form4_1706909035.xml · nonDerivative · entry 2 Norton Johna · CIK 0001702471 · EVP, Global Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,816 Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:24 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 1,268 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000017 · wk-form4_1706909035.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · EVP, Global Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2023 Filed Jun 15, 2023 20:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,647 | $448.00 | $737,856.00 |
DisclosureSEC source: 0000059478-23-000188 · wk-form4_1686860461.xml · nonDerivative · entry 2 Norton Johna · CIK 0001702471 · EVP, Global Quality 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,114 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 21, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 20:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,647 | $444.29 | $731,745.63 |
DisclosureSEC source: 0000059478-23-000188 · wk-form4_1686860461.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · EVP, Global Quality 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,761 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 21, 2023. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:32 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-23-000077 · wf-form4_167701512962950.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · EVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,408 Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:52 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 1,268 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-23-000057 · wf-form4_167641155807782.xml · derivative · entry 5 Norton Johna · CIK 0001702471 · EVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,268 Underlying: Common Stock · 1,268 shares Expires 2024-02-01 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:52 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 2,507 | $345.12 | $865,215.84 |
DisclosureSEC source: 0000059478-23-000057 · wf-form4_167641155807782.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · EVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,908 Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:54 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 2,102 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-23-000037 · wf-form4_167546127265548.xml · derivative · entry 6 Norton Johna · CIK 0001702471 · EVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,102 shares Expires 2023-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:54 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 941 | $344.15 | $323,845.15 |
DisclosureSEC source: 0000059478-23-000037 · wf-form4_167546127265548.xml · nonDerivative · entry 2 Norton Johna · CIK 0001702471 · EVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,401 Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:54 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 2,102 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-23-000037 · wf-form4_167546127265548.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · EVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 23:22 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 2,102 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-22-000046 · wf-form4_164462174983605.xml · derivative · entry 5 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,102 Underlying: Common Stock · 2,102 shares Expires 2023-02-01 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 23:22 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 3,294 | $243.27 | $801,331.38 |
DisclosureSEC source: 0000059478-22-000046 · wf-form4_164462174983605.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,240 Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:59 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 2,676 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-22-000028 · wf-form4_164392557628191.xml · derivative · entry 6 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,676 shares Expires 2022-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:59 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 1,194 | $245.39 | $292,995.66 |
DisclosureSEC source: 0000059478-22-000028 · wf-form4_164392557628191.xml · nonDerivative · entry 2 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,946 Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:59 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 2,676 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-22-000028 · wf-form4_164392557628191.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,140 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:36 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 2,676 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000052 · wf-form4_161300734811911.xml · derivative · entry 5 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,676 Underlying: Common Stock · 2,676 shares Expires 2022-02-01 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:36 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 6,040 | $205.77 | $1,242,850.80 |
DisclosureSEC source: 0000059478-21-000052 · wf-form4_161300734811911.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,464 Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:38 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 3,435 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000024 · wf-form4_161239548901874.xml · derivative · entry 6 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,435 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:38 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 1,529 | $207.97 | $317,986.13 |
DisclosureSEC source: 0000059478-21-000024 · wf-form4_161239548901874.xml · nonDerivative · entry 2 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,424 Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:38 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 3,435 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000024 · wf-form4_161239548901874.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2020 Filed Feb 2, 2021 22:16 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 156 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000016 · wf-form5_161230415317974.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,518 Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 14:44 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 4,727 | $131.00 | $619,237.00 |
DisclosureSEC source: 0000059478-20-000074 · wf-form4_158454263137522.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,674 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2020. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 19:57 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 97 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000054 · wf-form4_158205580329645.xml · derivative · entry 6 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by partner Disclosed balance after: 0 Underlying: Common Stock · 97 shares Expires 2020-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 19:57 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 34 | $141.12 | $4,798.08 |
DisclosureSEC source: 0000059478-20-000054 · wf-form4_158205580329645.xml · nonDerivative · entry 2 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by partner Disclosed balance after: 128 Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 19:57 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 97 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000054 · wf-form4_158205580329645.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by partner Disclosed balance after: 162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:46 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 3,435 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000034 · wf-form4_158163396149191.xml · derivative · entry 5 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,435 Underlying: Common Stock · 3,435 shares Expires 2021-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:46 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 1,778 | $144.25 | $256,476.50 |
DisclosureSEC source: 0000059478-20-000034 · wf-form4_158163396149191.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,401 Read SEC document |
| March 07, 2019 Filed Feb 3, 2020 21:50 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 196 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000014 · wf-form5_158076658467404.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,623 Read SEC document |
| February 16, 2019 Filed Feb 20, 2019 20:52 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 48 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000112 · wf-form4_155069590817698.xml · derivative · entry 6 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by partner Disclosed balance after: 97 Underlying: Common Stock · 48 shares Expires 2020-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest in three installments, 48 on February 16, 2018; 48 on February 16, 2019; and 97 on February 16, 2020. Read SEC document |
| February 16, 2019 Filed Feb 20, 2019 20:52 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 17 | $122.48 | $2,082.16 |
DisclosureSEC source: 0000059478-19-000112 · wf-form4_155069590817698.xml · nonDerivative · entry 2 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by partner Disclosed balance after: 65 Read SEC document |
| February 16, 2019 Filed Feb 20, 2019 20:52 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 48 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000112 · wf-form4_155069590817698.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by partner Disclosed balance after: 82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2019 Filed Feb 7, 2019 00:22 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 2,958 | $120.17 | $355,462.86 |
DisclosureSEC source: 0000059478-19-000057 · wf-form4_154949893755930.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,817 Read SEC document |
| February 04, 2019 Filed Feb 20, 2019 20:46 UTC Amendment | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 2,960 | $120.17 | $355,703.20 |
DisclosureSEC source: 0000059478-19-000109 · wf-form4a_155069557190530.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,819 F1 · shares: This amendment is being filed to correctly report the amount acquired in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5. F1 · balance_after: This amendment is being filed to correctly report the amount acquired in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5. Read SEC document |
| November 03, 2018 Filed Nov 6, 2018 18:25 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 3,133 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000258 · wf-form4_154152872203725.xml · derivative · entry 6 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,133 shares Expires 2018-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| November 03, 2018 Filed Nov 6, 2018 18:25 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 1,366 | $106.75 | $145,820.50 |
DisclosureSEC source: 0000059478-18-000258 · wf-form4_154152872203725.xml · nonDerivative · entry 2 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,859 Read SEC document |
| November 03, 2018 Filed Nov 6, 2018 18:25 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 3,133 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000258 · wf-form4_154152872203725.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 15:28 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 48 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000091 · wf-form4_151922689429729.xml · derivative · entry 6 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by partner Disclosed balance after: 145 Underlying: Common Stock · 48 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest in three installments, 48 on February 16, 2018; 48 on February 16, 2019; and 97 on February 16, 2020. F2 · derivative.expiration_date: The Restricted Stock Units vest in three installments, 48 on February 16, 2018; 48 on February 16, 2019; and 97 on February 16, 2020. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 15:28 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 14 | $78.02 | $1,092.28 |
DisclosureSEC source: 0000059478-18-000091 · wf-form4_151922689429729.xml · nonDerivative · entry 2 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by partner Disclosed balance after: 34 Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 15:28 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 48 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000091 · wf-form4_151922689429729.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by partner Disclosed balance after: 48 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 23:08 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 1,599 | $87.60 | $140,072.40 |
DisclosureSEC source: 0000059478-18-000046 · wf-form4_151744008557820.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,092 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.